Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The endocannabinoid system and related lipids as potential targets for the treatment of migraine‐related pain
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, et al.
Headache The Journal of Head and Face Pain (2022) Vol. 62, Iss. 3, pp. 227-240
Closed Access | Times Cited: 18

Showing 18 citing articles:

Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain
János Tajti, Délia Szok, Anett Csáti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4114-4114
Open Access | Times Cited: 56
Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain
Giuseppina Crescente, Giuseppe Minervini, Carmela Spagnuolo, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 106-106
Open Access | Times Cited: 50
Resistant and refractory migraine: clinical presentation, pathophysiology, and management
Raffaele Ornello, Anna P. Andreou, Eleonora De Matteis, et al.
EBioMedicine (2023) Vol. 99, pp. 104943-104943
Open Access | Times Cited: 25
Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings
Chiara Demartini, Miriam Francavilla, Anna Maria Zanaboni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5334-5334
Open Access | Times Cited: 24
Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice
Erik Zorrilla, Georgii Krivoshein, Adisa Kuburas, et al.
Cephalalgia (2025) Vol. 45, Iss. 2
Closed Access | Times Cited: 1
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
Rosaria Greco, Miriam Francavilla, Chiara Demartini, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 14
New Oral Drugs for Migraine
Nazia Karsan, Peter J. Goadsby
CNS Drugs (2022) Vol. 36, Iss. 9, pp. 933-949
Open Access | Times Cited: 19
Acute and chronic cannabidiol treatment: In vitro toxicological aspects on human oral cells
Stefano Pagano, Chiara Valenti, Paolo Negri, et al.
Food and Chemical Toxicology (2024) Vol. 185, pp. 114513-114513
Closed Access | Times Cited: 4
Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials
Alqassem Y. Hakami, Fahad S. Alshehri
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The Interplay between 2-Arachidonoylglycerol and Anandamide Amidohydrolase in Neuropathy
Iddrisu Ibrahim, Joseph Ayariga, Junhuan Xu, et al.
(2024)
Open Access | Times Cited: 3
UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders
Martha Nicholas, Simon Erridge, Lara Bapir, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 1, pp. 85-96
Open Access | Times Cited: 8
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Bibliometric Analysis of Global Research on Transient Receptor Potential Vanilloid 1 in the Field of Pain
Sisi Wang, Wen Wang, Xiangming Ye
Journal of Pain Research (2023) Vol. Volume 16, pp. 1517-1532
Open Access | Times Cited: 4
Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine
Jennifer Robblee
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 4
Research Trend in The Inhibition of Transient Receptor Potential Vanilloid 1 (TRPV1): Bibliometric Analysis and Visualization
Shereen M. Aleidi, Amani A. Harb, Lina A. Dahabiyeh, et al.
Journal of Applied Pharmaceutical Science (2024)
Open Access | Times Cited: 1
Natural Products Derived from Cannabis sativa for Pain Management
Erika Liktor‐Busa, Tally M. Largent‐Milnes
Handbook of experimental pharmacology (2024)
Closed Access
Expression of Cannabinoid Receptors in the Trigeminal Ganglion of the Horse
Rodrigo Zamith Cunha, Alberto Semprini, Giulia Salamanca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15949-15949
Open Access | Times Cited: 1
Potentially Remediable Shortcomings in the Contemporary Drug Treatment of Migraine
Mervyn J. Eadie
Future Pharmacology (2022) Vol. 2, Iss. 4, pp. 579-594
Open Access
Page 1

Scroll to top